Scopus İndeksli Yayınlar: Recent submissions

Now showing items 61-64 of 64

    • Transcriptional splice variants of CD40 and its prognostic value in breast cancer 

      Unver, Nese and Yoyen Ermis, Digdem and Weber, Bahar Zehra and Esendagli, Gunes (2020)
      CD40 is an important tumor necrosis factor receptor (TNFR) family protein for the development of antitumor response against cancer cells, apart from its role in the regulation of the immune system as a costimulatory molecule. ...

    • The effect of passive smoking on the etiology of serous otitis media in children 

      Tarhun, Yosunkaya M. (2020)
      Serous otitis media (SOM) is a disease mostly seen in the pediatric age group and characterized by serous effusion in the middle ear. The disease which is mostly silent can cause permanent hearing loss if it is not diagnosed ...

    • The effect of idiopathic premature ventricular complexes on left ventricular ejection fraction 

      Altintas, Bernas; Ozkalayci, Flora; Cinier, Goksel; Kaya, Ilyas; Aktan, Adem; Kup, Ayhan; Onuk, Rasit; Ozcan, Sevgi; Uslu, Abdulkadir; Akyuz, Abdurrahman; Atici, Adem; Ekinci, Selim; Akin, Halil; Yilmaz, Mehmet Fatih; Koc, Sahbender; Tanik, Veysel Ozan; Harbalioglu, Hazar; Barman, Hasan Ali; Afsin, Abdulmecit; Gumusdag, Ayca; Alibasic, Hayrudin; Karabag, Yavuz; Cap, Murat; Baysal, Erkan; Tanboga, Ibrahim Halil (2020)
      Aim Current literature lacks a definitive threshold of idiopathic premature ventricular complex (PVC) burden for predicting cardiomyopathy (CMP). The main objective of the present study was to evaluate relationship ...

    • Effects of low-dose unfractionated heparin on early brain injury after subarachnoid hemorrhage in mice 

      Altay, Orhan; Suzuki, Hidenori; Hasegawa, Yu; Altay, Bilge Nur; Tang, Jiping; Zhang, John H. (2020)
      Background: Sphingosine kinase (SphK) 1 has been reported as an important signaling node in anti-apoptotic signaling. Heparin is a pleiotropic drug that antagonizes many pathophysiological mechanisms. In this study, we ...